GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
- Posted on June 9, 2026
- By CNBC
- 0 Views
- 1 min read
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
